iShares U.S. Medical Devices ETF (IHI)

Key Metrics

TER 38.00% per year

Distribution policy Distributing

Fund size USD 3,174 M

Inception date May 1, 2006

Holdings 51

Fund currency USD

Fund domicile US

Provider iShares

For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Historical Return

Last updated: Jun 01, 2026

1 Year -20.5% +0.5% Div

3 Years (avg.) -2.9% +0.5% Div

5 Years (avg.) -2.7% +0.5% Div

Risk & Analysis Metrics

Last updated: Jun 01, 2026

Volatility

16.01% 1 Year

16.59% 3 Years

18.66% 5 Years

19.63% 10 Years

Max Drawdown

-26.24% 1 Year

-26.95% 3 Years

-33.79% 5 Years

-33.79% 10 Years

Sharpe Ratio

-1.48 1 Year

-0.35 3 Years

-0.28 5 Years

0.28 10 Years

Return Triangle (Heatmap)

Last updated: Jun 01, 2026

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2011	-1.6%	5.5%	14.4%	16.4%	14.8%	14.2%	16.4%	16.0%	18.0%	18.5%	18.8%	15.0%	14.0%	13.6%	13.2%
2012		13.2%	23.3%	23.2%	19.3%	17.7%	19.7%	18.7%	20.8%	21.0%	21.1%	16.7%	15.4%	14.9%	14.3%
2013			34.4%	28.5%	21.4%	18.9%	21.0%	19.7%	21.9%	22.1%	22.0%	17.0%	15.6%	15.1%	14.4%
2014				22.9%	15.4%	14.1%	17.9%	17.0%	19.9%	20.4%	20.6%	15.3%	13.9%	13.4%	12.9%
2015					8.4%	10.0%	16.2%	15.5%	19.3%	20.0%	20.2%	14.3%	13.0%	12.5%	12.0%
2016						11.6%	20.4%	18.0%	22.2%	22.4%	22.3%	15.2%	13.5%	13.0%	12.3%
2017							29.9%	21.3%	26.0%	25.3%	24.6%	15.8%	13.8%	13.2%	12.4%
2018								13.4%	24.1%	23.8%	23.3%	13.2%	11.4%	11.0%	10.4%
2019									35.9%	29.4%	26.8%	13.2%	11.0%	10.6%	10.0%
2020										23.2%	22.5%	6.5%	5.5%	6.1%	6.2%
2021											21.8%	-1.0%	0.1%	2.2%	3.1%
2022												-19.6%	-9.2%	-3.6%	-1.1%
2023													2.6%	5.6%	5.9%
2024														8.8%	7.7%
2025															6.6%

Distributions

*by ETF Portfolio Weight Last updated: Jun 01, 2026

Profit Margin Distribution

< 0%

1y 3y N/A N/A

0 - 5%

1y 3y N/A N/A

5 - 10%

16%

1y 3y N/A N/A

10 - 15%

12%

1y 3y N/A N/A

15 - 20%

31%

1y 3y N/A N/A

20 - 30%

35%

1y 3y N/A N/A

30 - 40%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

1y 3y N/A N/A

15 - 20

14%

1y 3y N/A N/A

20 - 25

19%

1y 3y N/A N/A

25 - 35

10%

1y 3y N/A N/A

35 - 50

25%

1y 3y N/A N/A

> 50

26%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.0%

1y 3y N/A N/A

Small Cap

2.4%

1y 3y N/A N/A

Mid Cap

8.4%

1y 3y N/A N/A

Large Cap

89.2%

1y 3y N/A N/A

Mega Cap

0.0%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: May 31, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$84.7B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	0.36%	2.02%
Beta Indicates the relationship between the price performance of a share and the market.	1.0	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	35.84	29.69
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-39.54	-
Profitable Companies	95%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	22.61	17.06
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	7.03	7.44
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	7.02	11.28

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	33.35	21.27
Enterprise Value to Revenue Enterprise value divided by revenue	7.67	8.71
Total Debt to Enterprise Value Total debt divided by enterprise value	0.09	0.04
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	0.45	0.27
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	16.74%	21.08%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+10.2%	-107.0%
Return on Equity Equity divided by market cap.	16.93%	3.50%
Return on Assets Indicates a company's profitability in relation to its total assets.	10.26%	4.45%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	16.00%	4.22%

Sectors

Manufacturing	65.4%
Healthcare	4.4%
Professional, Scientific, and Technical Services	0.2%
Other	30.1%

Countries

United States	91.4%
Ireland	7.6%
United Kingdom	0.6%
Jersey	0.3%
Other	0.1%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Intuitive Surgical Inc

ISRG - Manufacturing

Market Cap $150.39B

P/E Ratio 50.6

Dividends 0.0%

Total Investment $494.12M

Weight 15.57%

Loading details…

Stryker Corp.

SYK - Manufacturing

Market Cap $116.96B

P/E Ratio 35.0

Dividends 1.1%

Total Investment $341.59M

Weight 10.76%

Loading details…

Becton Dickinson & Co.

BDX - Manufacturing

Market Cap $53.3B

P/E Ratio 36.3

Dividends 2.4%

Total Investment $145.13M

Weight 4.57%

Loading details…

Edwards Lifesciences Corp

EW - Manufacturing

Market Cap $49.79B

P/E Ratio 45.8

Dividends 0.0%

Total Investment $141.75M

Weight 4.47%

Loading details…

Idexx Laboratories, Inc.

IDXX - Manufacturing

Market Cap $44.45B

P/E Ratio 41.2

Dividends 0.0%

Total Investment $140.92M

Weight 4.44%

Loading details…

Resmed Inc.

RMD - Manufacturing

Market Cap $27.64B

P/E Ratio 18.4

Dividends 1.3%

Total Investment $140.76M

Weight 4.43%

Loading details…

GE HealthCare Technologies Inc

GEHC

Market Cap $28.36B

P/E Ratio 18.9

Dividends 0.2%

Total Investment $139.63M

Weight 4.40%

Loading details…

Boston Scientific Corp.

BSX - Healthcare

Market Cap $175.45B

P/E Ratio 20.2

Dividends 0.0%

Total Investment $135.73M

Weight 4.28%

Loading details…

Dexcom Inc

DXCM - Manufacturing

Market Cap $28.45B

P/E Ratio 30.5

Dividends 0.0%

Total Investment $104.03M

Weight 3.28%

Loading details…

Zimmer Biomet Holdings Inc

ZBH - Manufacturing

Market Cap $15.93B

P/E Ratio 21.1

Dividends 1.2%

Total Investment $77.13M

Weight 2.43%

Loading details…

Hologic, Inc.

HOLX - Manufacturing

Market Cap $16.97B

P/E Ratio 31.4

Dividends 0.0%

Total Investment $72.41M

Weight 2.28%

Loading details…

Insulet Corporation

PODD - Manufacturing

Market Cap $10.04B

P/E Ratio 33.5

Dividends 0.0%

Total Investment $63.54M

Weight 2.00%

Loading details…

Penumbra Inc

PEN - Manufacturing

Market Cap $12.52B

P/E Ratio 73.1

Dividends 0.0%

Total Investment $55.45M

Weight 1.75%

Loading details…

Globus Medical Inc - Ordinary Shares - Class A

GMED - Manufacturing

Market Cap $11.04B

P/E Ratio 18.9

Dividends 0.0%

Total Investment $41.32M

Weight 1.30%

Loading details…

Baxter International Inc.

BAX - Manufacturing

Market Cap $9.7B

P/E Ratio -8.8

Dividends 1.1%

Total Investment $37.2M

Weight 1.17%

Loading details…

Masimo Corp

MASI - Manufacturing

Market Cap $9.34B

P/E Ratio 122.1

Dividends 0.0%

Total Investment $34.96M

Weight 1.10%

Loading details…

Glaukos Corporation

GKOS - Manufacturing

Market Cap $6.07B

P/E Ratio -31.7

Dividends 0.0%

Total Investment $26.63M

Weight 0.84%

Loading details…

Teleflex Incorporated

TFX - Manufacturing

Market Cap $5.69B

P/E Ratio -5.6

Dividends 1.1%

Total Investment $22.77M

Weight 0.72%

Loading details…

Envista Holdings Corp

NVST - Manufacturing

Market Cap $3.83B

P/E Ratio 57.0

Dividends 0.0%

Total Investment $17.91M

Weight 0.56%

Loading details…

iRhythm Technologies Inc

IRTC - Manufacturing

Market Cap $3.74B

P/E Ratio -133.3

Dividends 0.0%

Total Investment $16.38M

Weight 0.52%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

BSX DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - BSX

BSX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Boston Scientific Corporation of Class Action Lawsuit and Upcoming Deadlines – BSX

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

Intuitive Surgical Inc

Intuitive Surgical Inc

Stryker Corp.

Stryker Corp.

Becton Dickinson & Co.

Becton Dickinson & Co.

Edwards Lifesciences Corp

Edwards Lifesciences Corp

Idexx Laboratories, Inc.

Idexx Laboratories, Inc.

Resmed Inc.

Resmed Inc.

GE HealthCare Technologies Inc

GE HealthCare Technologies Inc

Boston Scientific Corp.

Boston Scientific Corp.

Dexcom Inc

Dexcom Inc

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Hologic, Inc.

Hologic, Inc.

Insulet Corporation

Insulet Corporation

Penumbra Inc

Penumbra Inc

Globus Medical Inc - Ordinary Shares - Class A

Globus Medical Inc - Ordinary Shares - Class A

Baxter International Inc.

Baxter International Inc.

Masimo Corp

Masimo Corp

Glaukos Corporation

Glaukos Corporation

Teleflex Incorporated

Teleflex Incorporated

Envista Holdings Corp

Envista Holdings Corp

iRhythm Technologies Inc

iRhythm Technologies Inc

Cookie Settings